key: cord-0811120-0bj1asxg
authors: Azad, Iqbal; Khan, Tahmeena; Maurya, Akhilesh Kumar; Irfan Azad, Mohd.; Mishra, Nidhi; Alanazi, Amer M.
title: Identification of Severe Acute Respiratory Syndrome Coronavirus‐2 inhibitors through in silico structure‐based virtual screening and molecular interaction studies
date: 2021-06-15
journal: J Mol Recognit
DOI: 10.1002/jmr.2918
sha: f13b6d4d041f3dcfa787de5ee85bc85b03be1537
doc_id: 811120
cord_uid: 0bj1asxg

The novel coronavirus Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) or COVID‐19 has caused a worldwide pandemic. The fatal virus has affected the health of human beings as well as the socio‐economic situation all over the world. To date, no concrete medicinal solution has been proposed to combat the viral infection, calling for an urgent, strategic, and cost‐effective drug development approach that may be achievable by applying targeted computational and virtual screening protocols. Immunity is the body's natural defense against disease‐causing pathogens, which can be boosted by consuming plant‐based or natural food products. Active constituents derived from natural sources also scavenge the free radicals and have anti‐inflammatory activities. Herbs and spices have been used for various medicinal purposes. In this study, 2,96 365 natural and synthetic derivatives (ligands) belonging to 102 classes of compounds were obtained from PubChem and assessed on Lipinski's parameters for their potential bioavailability. Out of all the derivatives, 3254 obeyed Lipinski's rule and were virtually screened. The 115 top derivatives were docked against SARS‐CoV‐2, SARS‐CoV, MERS‐CoV, and HCoV‐HKV1 main proteases (M(pro)s) as receptors using AutoDock Vina, AutoDock, and iGEMDOCK 2.1. The lowest binding energy was exhibited by ligands 2 and 6 against all the four M(pro)s. The molecular dynamic simulation was also performed with ligand 6 using the GROMACS package. Good bioactivity scores, absorption, distribution, metabolism, excretion, and toxicity profile and drug‐like pharmacokinetic parameters were also obtained. Hydroxychloroquine was used as the control drug.

Out of these, the SARS and MERS coronaviruses were highly pathogenic 1 and associated with high mortality. In December 2019, the third Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was identified from China as the newest pathogenic virus of the βCoV lineage. 2 By March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic, which is still unfolding and the scientific fraternity does not have any targeted medicinal solution to combat this disease. The novel coronavirus possesses high mutability, making it susceptible to rapid spread, owing to its ribonucleic genetic material. RNA viruses are usually less stable than their DNA counterparts with high mutation ability 3 showing that the virus may mutate and acquire a less treatable form in a short period. Recent epidemiological studies have also confirmed that the mutated SARS-CoV-2 may be more contagious. 4 The known coronaviruses are associated with acute respiratory distress syndrome leading to reduced lung function, or even death in severe cases. SARS-CoV-2 has a lower mortality rate than MERS-CoV and SARS-CoV, but has a faster spread rate 5 and is difficult to contain. It is crucial to comprehend the host hijacking mechanism for drug development. To date, there are no marketed drugs against SARS-CoV, SARS-CoV-2, and MERS-CoV, although clinical trials are underway with RNA polymerase (RdRP) inhibitor remdesivir 6 and research has suggested that nucleoside analogs may prove beneficial against SARS-CoV-2. 7 CoVs generally contain 16 non-structural (nsp-16) proteins along with spike (S), membrane (M), nucleocapsid (N), and envelop (E) proteins. 8 The envelope-anchored spike protein is a crucial determinant required for the viral interaction and is one of the first components to come in contact with the infected host. 9 Previous studies suggest that both SARS-CoV-2 and SARS-CoV cause infection through the association of the Receptor-binding domain (RBD) to angiotensin-converting enzyme 2 (ACE2). 10 Several molecular targets have been identified in search of new antiviral drugs. The X-ray structure of SARS-CoV-2 has been recently explored for computational analysis. Computational chemistry offers an effective solution in the development of potential lead compounds, in a time and cost-effective manner. Computational strategies include molecular dynamics (MD) and virtual screening 11 and computational tools have been explored to develop probable SARS-CoV-2 M pro inhibitors. SARS-CoV-2 M pro interacts with the active sites and releases the RNA into the host cell and infects the same. 12 It replicates itself and mainly affects the respiratory system. Hence, there is an imperative need to identify a SARS-CoV-2 M pro inhibitor. The CoV M pro s are enveloped positive-stranded RNA viruses with the largest viral RNA genomes ranging between 27 and 31 kb. 13 The CoV replicase gene has two polyproteins, termed pp1a and pp1b, which govern the replication and transcription. 14 Most maturation cleavage events are governed by the CoV M pro or 3CL protease or 3CL pro , a three-domain (domains I to III) cysteine protease. 15 The structures of CoV M pro revealed the formation of an active homodimer, 16,17 the 1-7 N-terminal residues of the M pro have an important role in the proteolytic action 18 and the C-terminal domain is essential for dimerization. 19 Computational tools help in understanding the interaction between small molecules, also known as ligands and receptors. 20 Molecular docking and MD simulation find application in the assessment of the binding affinity of the probable lead molecule with the receptor. Molecular docking studies predict the binding energy when a ligand binds to the receptor and the interaction affinity. 21 MD simulation is used to simulate a protein to know the dynamic behavior of the system. The simulating entities are taken in a box either at a fixed or varying temperature. Replica exchange molecular dynamics (REMD) can be used to study the inhibition of the protease with a variation in temperature. 22 The present study is aimed at the development of a probable inhibitor of CoV M pro s, including SARS-CoV-2, with the help of in silico and virtual screening of the bioactive constituents (natural and synthetic derivatives) of some commonly occurring herbs and spices against the target protein. Spices and herbs have found a prominent role as flavoring and aroma inducing agents. They are also useful as coloring or preservative agents and used for medicinal purposes. 23 They also offer an array of benefits against acute, chronic, and noncommunicable ailments. Their active constituents are rich in sulfurcontaining compounds, alkaloids, tannins, terpenoids, vitamins, flavonoids, etc 24 They also contain saponins, enzymes, and minerals, including selenium, copper, manganese, zinc, chromium, iodine, etc.

Spices also possess exceptional antioxidant activity as they are rich in phenolic compounds. 25 Other than antioxidant potential, the bioactive constituents are also responsible for anti-inflammatory, anti-tumorigenic, and anti-carcinogenic activities along with blood sugar and cholesterol-lowering activities. 26 Studies support that spice consumption reduces the risk of mortality associated with cancer, heart, and respiratory diseases. A recent study in China with 487 375 participants related to the consumption of spicy foods as part of their diet concluded the inclusion of spices in food to improve and maintain health. 27 The present study took into account the computational pharmacokinetics and drug-likeness assessment of the hit molecules, in search of a potential inhibitor of the SARS-CoV, SARS-CoV-2, HCoV-HKU1, and MERS-CoV M pro s. The protein-ligand binding was studied through molecular docking and MD simulation was performed to measure the stability of the best protein-ligand complex.

The crystal structure of the target protein is the most accurate model for the evaluation of protein-ligand interaction. Several important criteria need to be considered before the selection of the appropriate crystal structure of the target protein viz. (a) minimum possible resolution or maximum quality of the target protein; (b) identification of the crystal structure based on domain completeness. The full structure of the studied protein must be available, and there should not be any gap between the residues, as partial domain leads to inaccurate analysis, (c) any mutation in the target protein of interest must be avoided, (d) the side chains of the crystal structure must be small so that the ligand does not interact with them, (e) identification of the complete structure of the target protein is necessary, as partial domain would lead to an incorrect evaluation, and the confirmation must be done based on its sequence analysis, (f) presence of crystalline water/cofactor/ligands also favors the selection of desirable target proteins, as the attachment of a ligand shows that the target protein is mimicking Table S2 along with their coordinates. The most interactive and suitable grids were, Grid IV for SARS-CoV, Grid II for HCoV-HKU1, Grid I for MERS-CoV, and Grid II for SARS-CoV-2 M pro s (Table S1) 

In developing countries like India and China, a plant-based medicine system has been used for ages for the improvement of health and well-being. WHO has predicted that the majority of the world population relies upon medicine based on herbal sources. 28 Herbs and spices have been used as food additives 29 and derived from roots, barks, seeds, fruits, flowers, etc. 30 They are used to enhance aroma, as flavoring agents and for various medicinal purposes. Their bioactive constituents have the potential to decrease the risk of diabetes, obesity, cancer, and cardiovascular disease. 31 Their bioactive constituents have innumerable medicinal benefits like purgative, laxative, expectorant, carminative, diuretic, etc. Spices have a range of functions and protect the human body against many illnesses and disorders. 32 In this study, 2,96,365 plant-based natural and synthetic derivatives were extracted from PubChem (Table S2) , for further exploration of their binding potential with the CoV M pro s. The docking interactions were also studied against the two physiological ligands (MPD and PRD) and hydroxychloroquine (HCQ) as a reference drug.

Spike, envelop, membrane, protease, and nucleocapsid proteins are some of the potential target sites explored for drug designing against coronaviruses. Sixteen nonstructural polyproteins (NSPs) containing PP1a and PP1b are found in the genome of coronavirus encoded by replicase. 33 The release of NSPs is facilitated by the protease. The cysteine protease or M pro or 3-C like protease (3CL pro ) leads to the cleavage at the C-terminal of the polyprotein. The Cys-His dyad is responsible for the protease activity. 34 The protease cleaves at 11 specific sites in the p1 region of PP1a and PP1ab facilitating replication of the virus and release of the NSPs. Human immunodeficiency virus (HIV) protease inhibitors like lopinavir and ritonavir have shown inhibitory action against M pro s. In this study, the M pro was selected as the target protein, and through flexible docking, the binding interaction with the selected ligands was unleashed.

Crystalline structures of the selected ligands were obtained from PubChem (https://pubchem.ncbi.nlm.nih.gov). Overall, 2,76, 225 derivatives were found in the database. To obtain the potential lead entity, the ligands were filtered on Lipinski's rule of bioavailability, which is essential to be known in a promising drug moiety to know how the dose reaches the bloodstream, upon oral administration. 35 Of all the selected ligands, 3254 obeyed Lipinski's rule and were further selected for virtual screening and molecular docking. Further optimization was done through Merck Molecular Force Field and MGL tools 1.5.6 was used for the preparation of ligand parameters. 2D and 3D structures of the ligands were viewed in ChemDraw 3D.

Replicase polyprotein 1a (pp1a) and replicase polyprotein 1b (pp1b) exist in the genome of coronavirus. 36 The viral 30 kb RNA genome open reading frame (ORF1a/b) consists of polyproteins (pp1a and pp1ab), accessory, spike, small envelope, matrix, and nucleocapsid proteins. In this study, pp1a was downloaded from the PDB. The open reading frame is important for defining the target genomic sequence. 37 Open reading frame 1a (ORF1a) was obtained from the Protein Data Bank. The structural procurement of target proteins was carried out by removing water, hit atom, ligands, and ions. Target proteins were also subjected to structural filtration through Chimera 1. (P) and temperature (T) for 100 ps time. After the equilibration, the complex system was subjected to run for 100 ns time of simulation with a step of 2 femtoseconds (fs) using leapfrog algorithm. After the F I G U R E 1 Schematic representation of the study completion of the runs, the generated trajectories were analyzed for the structural deviation between the ligand and the complex system and graphs were generated using MATLAB.

The diagrammatic representation of the study is given as Figure 1 .

The main aim of virtual screening is to assess a large collection of molecules against a specific target in a time and cost-effective manner. 

Evaluation of ADMET properties is a prerequisite for the pre-clinical analysis. 48 Cheminformatics has established many molecular descriptors based on chemical structures, including oral bioavailability and carcinogenicity. 50, 51 Ames toxicity assessment, which is used to assess the potential mutagenicity associated with a test chemical by treating the mutated Salmonella typhimurium strains with it. The top 13 ligands had positive HIA and BBB crossing potential. No carcinogenicity was found to be associated with any of the 13 ligands (Table 5) . To assess the HIA and BBB crossing ability, the Egan's egg was used to create the BOILED egg model, 52 The Polar surface area and the number of hydrogen bonds increase with the MW. 56 Hydrogen bonding also has a vital significance in biological systems, as extensive hydrogen bonding causes a delay in the movement of drugs from gut to blood. Drugs having partial rigid character generally possess good to excellent oral bioavailability. 57 LogP represents the solubility of the proposed compounds affecting the capacity of a molecule to pass through the cell membrane. 58 The MW of all the 13 ligands was within the limit of 500 and TPSA was below 140 Å 2 ( Table 6 ).

The bioavailability radar is a pictorial representation and assess- rotatable bonds <9. The pink area represents the optimal range for each parameter. The colored zone in the radar shows the best suited physiochemical space for oral bioavailability. The bioavailability radar predicted promising results for ligand 6 ( Figure 6 ). T A B L E 5 Absorption, distribution, mechanism, excretion, and toxicity (ADMET) analysis 

Ames mutagenesis; BBB, blood-brain barrier; Biodeg, biodegradability; Caco-2, Caco-2 permeability; Carcino, carcinogenesis; HIA, human intestinal absorption; HOB, human oral bioavailability; PPB, plasma protein binding (Unit = 100%)

SARS and other coronaviruses as causes of pneumonia

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2

Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?

Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan

Responding to Covid-19 a once-in-a-century pandemic?

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

An orally bioavailable broadspectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Neutralizing antibodies against SARSCoV-2 and other human coronaviruses

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor

Identification of potential riboflavin synthase inhibitors by virtual screening and molecular dynamics simulation studies

Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis

Coronaviruses: an overview of their replication and pathogenesis

The coronavirus replicase

Virus-encoded proteinases and proteolytic processing in the Nidovirales

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction

Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors

Pathological role of a point mutation (T315I) in BCR-ABL1 protein-a computational insight

Role of ELA region in auto-activation of mutant KIT receptor: a molecular dynamics simulation insight

In-silico homology assisted identification of inhibitor of RNA binding against

U R E 1 2 Interaction energy and binding stability of the targetligand complexes: A, Coulomb-SR energy

N-protein (N terminal domain)

Health benefits of culinary herbs and spices

Antioxidant activity of spices and their impact on human health: a review. Antioxidants (Basel)

Phenol-Explorer: an online comprehensive database on polyphenol contents in foods

Health-promoting properties of common herbs

Consumption of spicy foods and total and cause specific mortality: population-based cohort study

Some aspects of toxic contaminants in herbal medicines

Antimicrobial and chemopreventive properties of herbs and spices

Herb & Spice Companion: The Complete Guide to over 100 Herbs & Spices

Health potential of soy isoflavones for menopausal women

nMedicinal uses of spices used in our traditional culture: worldwide

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

Noncanonical junctions in subgenomic RNAs of SARS-CoV-2 lead to variant open reading frames. bio-Rxiv

Computational drug designing and prediction of important parameters using in silico methods-a review

Synthesis, quantum chemical study, AIM simulation, in silico ADMET profile analysis, Molecular Docking and antioxidant activity assessment of aminofuran derivatives

Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M pro ) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation

Structurebased virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme

In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation-based drug-repurposing

Finding potent inhibitors for COVID-19 main protease (M pro ): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA

Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach

Putative SARS-CoV-2 Mpro inhibitors from an in-house library of natural and natureinspired products: a virtual screening and molecular docking study

SARS-CoV-2 M pro inhibitors: identification of anti-SARS-CoV-2 M pro compounds from FDA approved drugs

Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone

Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor

admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties

admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules

The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Dis Today

Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl-and 2-acylloxyethylsulfonamides as potent anti-fungal agents

Molecular property filters describing pharmacokinetics and drug binding

Chemical reactivity, druglikeness and structure activity/property relationship studies of 2,1,3-benzoxadiazole derivatives as anti-cancer activity

Molecular properties that influence the oral bioavailability of drug candidates

Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents

Structural insights into conformational stability of both wild-type and mutant EZH2 receptor

Discovery of novel coumarin analogs against the α-glucosidase protein target of diabetes mellitus: pharmacophore-based QSAR, docking, and molecular dynamics simulation studies

Identification of Severe Acute Respiratory Syndrome Coronavirus-2 inhibitors through in silico structure-based virtual screening and molecular interaction studies

The authors declare they have no competing interests.

The data that supports the findings of this study are available in the supplementary material of this article

https://orcid.org/0000-0002-0467-4315